Abstract:With the rapid development of molecular subtyping and multi-omics analytical technologies, research on lung cancer metastasis has gradually shifted from traditional anatomical descriptions to exploration of the molecular regulatory mechanisms underlying organ-specific colonization. This review summarizes the heterogeneous characteristics of distant metastatic patterns among different histological types of lung cancer, with a focus on the selective distribution of adenocarcinoma, small cell lung cancer, and other subtypes in the brain, bone, and liver, as well as their potential biological mechanisms. Evidence from driver gene mutation profiles, multi-omics analyses, and tumor microenvironment features is integrated to elucidate the molecular basis of organ tropism in lung cancer metastasis. Furthermore, the roles of immune regulation and precision therapeutic strategies in metastatic risk assessment and clinical decision-making are discussed. This review provides a theoretical foundation for establishing precision diagnostic and therapeutic models based on histological subtypes and organ-specific metastatic characteristics.